NCT06610136

Brief Summary

Introduction: Several studies have evaluated and confirmed the ergogenic effect of acute caffeine intake on sports performance, specifically on strength and power performance. However, little is known about the prolonged effect of this supplement on neuromuscular adaptations to strength training. Introduction: Several studies have evaluated and confirmed the ergogenic effect of acute caffeine intake on sports performance, specifically on strength and power performance. However, little is known about the prolonged effects of this supplement on neuromuscular adaptations to strength training. Objectives: The present study aims to analyze the effects of acute and chronic caffeine intake on neuromuscular adaptations to strength training, according to sex (men vs. women) and type of exercise (bench press vs. squat), as well as on fatigue resistance during repeated sprints, fatigue perception, mood state, reaction time, diet, and potential side effects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 9, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 24, 2024

Completed
Last Updated

September 24, 2024

Status Verified

September 1, 2024

Enrollment Period

1.4 years

First QC Date

September 9, 2024

Last Update Submit

September 19, 2024

Conditions

Outcome Measures

Primary Outcomes (7)

  • Mean velocity at different %1RM

    Measuring bar mean velocity desplacement during bench press and back squat exercises.

    Through study completion, an average of 12 weeks

  • Peak velocity at different %1RM

    Measuring bar peak velocity and time to reach peak velocity of bar desplacement during bench press and back squat exercises.

    Through study completion, an average of 12 weeks

  • Mean power output at different %1RM

    Measuring during bench press and back squat exercises.

    Through study completion, an average of 12 weeks

  • Peak power output and time to reach peak power output at different %1RM

    Measuring during bench press and back squat exercises.

    Through study completion, an average of 12 weeks

  • Number of repetitions performed at 65%1RM until task failure

    In bench press and back squat exercises

    Through study completion, an average of 12 weeks

  • Bar velocity deplacement performed in 1 set at 65%1RM until task failure

    In bench press and back squat exercises

    Through study completion, an average of 12 weeks

  • Power output generated in 1 set at 65%1RM until task failure

    In bench press and back squat exercise

    Through study completion, an average of 12 weeks

Secondary Outcomes (8)

  • Resting Metabolic Rate (RMR)

    Through study completion, an average of 12 weeks

  • Maximal Fat Oxidation Rate (MFO)

    Through study completion, an average of 12 weeks

  • Fat mass

    Through study completion, an average of 12 weeks

  • Fat-free mass

    Through study completion, an average of 12 weeks

  • Physical activity (METs-min/wk)

    Through study completion, an average of 12 weeks

  • +3 more secondary outcomes

Study Arms (4)

Caffeine - Males

EXPERIMENTAL
Dietary Supplement: Caffeine plus Resistance training

Placebo - Males

PLACEBO COMPARATOR
Other: Placebo + Resistance training

Caffeine - Females

EXPERIMENTAL
Dietary Supplement: Caffeine plus Resistance training

Placebo - Females

PLACEBO COMPARATOR
Other: Placebo + Resistance training

Interventions

Acute caffeine intake (3 mg/kg) prior each resistance training session of a 8 weeks training program.

Caffeine - FemalesCaffeine - Males

Acute placebo intake (3 mg/kg of maltodextrin) prior each resistance training session of a 8 weeks training program.

Placebo - FemalesPlacebo - Males

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age between ≥ 18 and ≤ 35 years.
  • Body mass index (BMI) \< 25 kg/m².
  • Physically active subjects (\>150 min/week of moderate exercise).
  • Healthy men and women without neurological, cardiometabolic, immunological, or physical conditions that prevent them from performing physical exercise.
  • Participants capable of performing the tests.

You may not qualify if:

  • History of neuromuscular, cardiac, or diseases that could affect liver or muscle metabolism.
  • Use of drugs or other stimulants that interfere with caffeine intake and intestinal absorption during the tests and study.
  • Body mass index (BMI) \> 25 kg/m².
  • Having undergone prolonged periods of forced physical inactivity during the 6 months prior to the study.
  • Performing strenuous exercise within 48 hours prior to the tests.
  • Failing to replicate the same food intake on the two experimental days.
  • Consuming caffeine after 6 PM on the day prior to training or testing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Facultad de Medicina y Ciencias de la Salud. Universidad de Alcalá

Alcalá de Henares, Madrid, 28805, Spain

Location

MeSH Terms

Interventions

CaffeineResistance Training

Intervention Hierarchy (Ancestors)

XanthinesAlkaloidsHeterocyclic CompoundsPurinonesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingExercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Statistician
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 9, 2024

First Posted

September 24, 2024

Study Start

January 15, 2023

Primary Completion

May 30, 2024

Study Completion

May 30, 2024

Last Updated

September 24, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

Locations